Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Melkon G DomBourian"'
Autor:
Kyle Annen, Melkon G DomBourian
Publikováno v:
Vox Sanguinis. 117:177-184
Blood donor opinions and behaviours regarding marijuana use are not well known nor is the potential impact to the blood supply. We sought to assess opinions and frequency of marijuana use in proximity to blood donation via a survey of blood donors at
Autor:
Vijaya Knight, Melkon G DomBourian, Patricia A. Merkel, Thomas E. Morrison, Kyle Annen, Mary K. McCarthy, Gillian Andersen, Eileen Schwartz, Leah Huey
Publikováno v:
Transfusion
Background In March 2020, the Food and Drug Administration (FDA) approved use of COVID‐19 convalescent plasma (CCP) as an investigational new drug for treatment of COVID‐19. Since then, collection of CCP from COVID‐19–recovered patients has b
Autor:
Ross M. Kedl, Jonathan Schultz, Cody Rester, Ashley Frazer-Abel, Katherine R. Sabourin, Kyle Annen, Vijaya Knight, Melkon G DomBourian, Mary K. McCarthy, Rosemary Rochford, Thomas Jaenisch, Thomas E. Morrison, Elan Z. Eisenmesser
Publikováno v:
J Clin Microbiol
Serological testing of large representative populations for antibodies to SARS-CoV-2 is needed to estimate seroprevalence, transmission dynamics, and the duration of antibody responses from natural infection and vaccination. In this study, a high-thr
Autor:
Sean C. Taylor, Kyle Annen, Beth Hurst, Vijaya Knight, Thomas E. Morrison, Melkon G DomBourian, Ashley Bailey, Jamil N. Kanji, Carmen L. Charlton, Leah Huey, Mary K. McCarthy
Publikováno v:
Journal of Clinical Microbiology
Many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology tests have proven to be less accurate than expected and do not assess antibody function as neutralizing, correlating with protection from reinfection. A new assay technology m
Publikováno v:
Clinics in laboratory medicine. 41(1)
Advances in cellular therapies for pediatric patients have created many opportunities for improved survival with reduced morbidity. This article reviews current cellular therapies in pediatric hematological malignancy, including the most updated prac
Autor:
Leah Huey, Melkon G DomBourian, Eileen Schwartz, Vijaya Knight, Patricia A. Merkel, Gillian Andersen, Kyle Annen, Mary K. McCarthy, Thomas E. Morrison
In March 2020, the FDA approved the use of COVID-19 convalescent plasma (CCP) as an investigational new drug for treatment of COVID-19. Since then, collection of CCP from COVID-19 recovered patients has been implemented in several donor centers acros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72732c720c36895974aee7a9f61d9d1d
https://doi.org/10.1101/2020.09.01.20185942
https://doi.org/10.1101/2020.09.01.20185942
Autor:
Melkon G DomBourian, Vijaya Knight, Patricia A. Merkel, Sarah Jung, Kyle Annen, Samuel R. Dominguez, Gillian Andersen, Leah Huey
Publikováno v:
Journal of Immunological Methods
Coronavirus Disease 2019 (COVID-19) convalescent plasma (CCP) was approved by the FDA for use in severe cases of COVID-19 under an emergency Investigational New Drug (IND) protocol. Eligibility criteria for CCP donors includes documentation of eviden
Autor:
Mary K. McCarthy, Kathy L. Rowlen, Leah Huey, Kyle Annen, Gillian Andersen, Erica D. Dawson, Thomas E. Morrison, Patricia A. Merkel, Melkon G DomBourian, Vijaya Knight
Publikováno v:
Journal of Immunological Methods
Mitigation of the COVID-19 pandemic requires an understanding of the antibody response to SARS-CoV-2. However, throughout the development of SARS-CoV-2 IgG antibody assays during the past year, cross-reactivity to other coronaviruses remained a quest
Autor:
Melkon G DomBourian, Lorne Holland
Publikováno v:
Journal of Infusion Nursing. 35:28-32
Fresh frozen plasma contains a number of therapeutically useful substances, most notably coagulation factors. As with any transfusion, there are risks associated with plasma transfusion. Ironically, the risk of viral transmission (human immunodeficie
Publikováno v:
Laboratory medicine. 46(1)
Methemoglobin (MetHb) is a form of hemoglobin in which heme iron is oxidized and unable to bind oxygen; its normal basal production is counteracted by an efficient MetHb-reduction pathway. The causes of methemoglobinemia are classified as congenital